Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

 

Rapamune (sirolimus) - Important safety information from Wyeth as approved by the Irish Medicines Board

31 January 2003

Tags: Human medicinesHealthcare professionalsDirect Healthcare Professional Communication2003

Please find attached important safety communication regarding the use of Rapamune (sirolimus) in de novo lung transplant patients


« View Publications List



Date Printed: 22 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971